Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phathom Pharmaceuticals

3.14
+0.850037.12%
Post-market: 3.240.1000+3.18%19:59 EDT
Volume:12.64M
Turnover:41.67M
Market Cap:218.70M
PE:-0.60
High:3.78
Open:2.33
Low:2.33
Close:2.29
Loading ...

Director Asit Parikh Reports Acquisition of Phathom Pharmaceuticals Common Shares

Reuters
·
Yesterday

Phathom Pharmaceuticals Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
03 May

Phathom Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
02 May

Phathom Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $20 From $28

THOMSON REUTERS
·
02 May

Phathom Pharmaceuticals Reports Q1 2025 Financial Results

TIPRANKS
·
02 May

Phathom Pharmaceuticals Eyes Profitability Amid Growth

TIPRANKS
·
02 May

Phathom Pharmaceuticals Inc. Announces New Compensation Plan with Inducement Awards for Senior VP Jonathan Bentley

Reuters
·
02 May

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
02 May

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
02 May

BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, Wayfair, Moderna

Reuters
·
02 May

Positive Outlook for Phathom Pharmaceuticals Amid Cost-Cutting and Regulatory Catalysts

TIPRANKS
·
02 May

Phathom Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
01 May

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
01 May

UPDATE: Phathom Pharmaceuticals Q1 Adj. EPS $(1.07) Beats $(1.15) Estimate,

Benzinga
·
01 May

Phathom Pharmaceuticals reports Q1 EPS ($1.07), consensus ($1.07)

TIPRANKS
·
01 May

BRIEF-Phathom Pharmaceuticals Q1 Net Income USD -94.316 Million

Reuters
·
01 May

Phathom Pharmaceuticals Inc - to Reduce Headcount by Approximately 6%

THOMSON REUTERS
·
01 May

Phathom Pharmaceuticals Inc - Implements Cost Reductions and Leadership Changes for Growth

THOMSON REUTERS
·
01 May

Phathom Pharmaceuticals Inc - Expects $60-$70 Million Reduction in 2025 Operating Expenses

THOMSON REUTERS
·
01 May

Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
01 May